Related Experiment Video
Updated: Jul 17, 2026
08:53
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
Neuronal ceroid lipofuscinosis: a common pathway?
Dixie-Ann Persaud-Sawin1, Talal Mousallem, Christine Wang
1Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Pediatric Research
|January 24, 2007
Summary
Neuronal ceroid lipofuscinoses (NCLs) are pediatric neurodegenerative diseases. This study reveals that NCL proteins interact, suggesting a shared pathway underlying these conditions.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Neuronal ceroid lipofuscinoses (NCLs) comprise a group of pediatric neurodegenerative disorders with shared clinical symptoms.
- Six of the nine known NCL variants (CLN1-CLN9) have been genetically identified, with most exhibiting cell death and altered sphingolipid metabolism.
Purpose of the Study:
- To investigate the functional interactions between proteins implicated in NCLs.
- To determine if defective NCL proteins interact within a common cellular pathway.
Main Methods:
- Utilized patient-derived cell lines with genetic defects in NCLs.
- Performed gene transfection with wild-type genes to assess rescue of cellular defects.
- Conducted co-immunoprecipitation and co-localization studies to analyze protein interactions and cellular localization.
Main Results:
- Cellular growth and apoptotic defects in NCL patient cell lines were reversed by wild-type gene transfection.
- Specific NCL proteins (CLN3, CLN6, CLN8) exhibited complementary functions, as did CLN1 and CLN2.
- CLN2 protein demonstrated broader complementation across multiple NCL variants (CLN3, CLN6, CLN8).
- Co-immunoprecipitation and co-localization studies confirmed interactions between CLN2, CLN3, CLN6, and CLN8 proteins in endosomes and lipid rafts, and between CLN1 and CLN2.
Conclusions:
- The findings support the hypothesis that NCL proteins interact at multiple points within a single cellular pathway.
- These interactions suggest a unified mechanism underlying the pathogenesis of various NCL forms.
- Understanding these protein interactions may offer new therapeutic targets for NCLs.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...